Semler Scientific, Inc. (NASDAQ:SMLR)

Wednesday, December 2, 2015 | Web News
Semler Scientific, Inc. is a medical risk assessment company. The Company develops, manufactures and markets products that assist healthcare providers in monitoring patients and evaluating chronic...
See All Research...
Monday, April 30, 2018, 12:33 PM
Has Semler Scientific (SMLR) Reached a Growth Inflection Point? [Reasons for Tracking]
Monday, November 30, 2015, 2:30 PM
Semler Scientific: New Contract Wins Scrutinized
See All Articles and Reports...
Semler Scientific, Inc. develops, manufactures, and markets patented products that assist healthcare providers to evaluate and treat patients with chronic diseases in the United States. Its products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition; and WellChec, a multi-test service platform to evaluate patients with various chronic diseases. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as organizations, including healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry; and other healthcare organizations, such as risk assessment groups and other home healthcare providers. It offers its products through salespersons and distributors. Semler Scientific, Inc. was founded in 2007 and is headquartered in San Jose, California.

Web site:

Last updated April 20, 2018